Galmed Pharmaceuticals Ltd. (GLMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Galmed Pharmaceuticals Lt...

    NASDAQ: GLMD · Real-Time Price · USD
    1.39
    0.01 (0.72%)
    At close: Sep 26, 2025, 3:58 PM
    1.42
    2.16%
    After-hours: Sep 26, 2025, 07:52 PM EDT

    Galmed Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 83K 31K 35K 42K
    Gross Profit
    		 -83K -31K -35K -42K
    Operating Income
    		 -6.28M 7.49M -17.65M -32.88M
    Interest Income
    		 503K 375K 297K 562K
    Pretax Income
    		 -7.52M -6.91M -17.87M -32.47M
    Net Income
    		 -7.52M -6.91M -18.57M -31.95M
    Selling & General & Admin
    		 3.3M 3.92M 4.66M 5.66M
    Research & Development
    		 2.98M 3.57M 12.99M 27.22M
    Other Expenses
    		 -83K -14.98M n/a n/a
    Operating Expenses
    		 6.2M -7.49M 17.65M 32.88M
    Interest Expense
    		 15K 11K 215K 43K
    Selling & Marketing Expenses
    		 40K 200K n/a n/a
    Cost & Expenses
    		 -6.28M -7.49M 17.65M 32.88M
    Income Tax Expense
    		 n/a n/a 705K -519K
    Shares Outstanding (Basic)
    		 930.82K 230K 1.68M 1.64M
    Shares Outstanding (Diluted)
    		 930.82K 230.79K 1.68M 1.64M
    EPS (Basic)
    		 -8.08 -30.05 -11.08 -19.48
    EPS (Diluted)
    		 -8.08 -29.95 -11.08 -19.48
    EBITDA
    		 -7.42M -6.87M -17.62M -32.84M
    EBIT
    		 -7.5M -6.9M -17.65M -32.88M
    Depreciation & Amortization
    		 83K 31K 35K 42K

    Add to Watchlist